These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12366713)

  • 41. Successful long-term control with lamivudine against reactivated hepatitis B infection following intensive chemotherapy and autologous peripheral blood stem cell transplantation in non-Hodgkin's lymphoma: experience of 2 cases.
    Nakagawa M; Simizu Y; Suemura M; Sato B
    Am J Hematol; 2002 May; 70(1):60-3. PubMed ID: 11994984
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection.
    Ahmed A; Keeffe EB
    Am J Gastroenterol; 1999 Jan; 94(1):249-51. PubMed ID: 9934765
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reactivation of precore mutant hepatitis B virus in chemotherapy-treated patients.
    Dai MS; Lu JJ; Chen YC; Perng CL; Chao TY
    Cancer; 2001 Dec; 92(11):2927-32. PubMed ID: 11753968
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute liver failure related to chemotherapy.
    Wijaya I; Sanityoso A; Lesmana LA
    Acta Med Indones; 2012 Apr; 44(2):145-9. PubMed ID: 22745146
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fibrosing cholestatic hepatitis secondary to precore/core promoter hepatitis B variant with lamivudine resistance: successful retransplantation with combination adefovir dipivoxil and hepatitis B immunoglobulin.
    Lo CM; Cheung ST; Ng IO; Liu CL; Lai CL; Fan ST
    Liver Transpl; 2004 Apr; 10(4):557-63. PubMed ID: 15048802
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fibrosing cholestatic hepatitis after living related-donor renal transplantation.
    Waguri N; Ichida T; Fujimaki R; Ishikawa T; Nomoto M; Asakura H; Nakamaru T; Saitoh A; Arakawa M; Saitoh K; Takahashi K
    J Gastroenterol Hepatol; 1998 Nov; 13(11):1133-7. PubMed ID: 9870801
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ductular reaction and hepatocyte ballooning identify patients with fibrosing cholestatic hepatitits after liver transplantation.
    Llovet LP; Sciarrone S; Rodríguez-Tajes S; Montironi C; Mescoli C; Rugge M; Crespo G; Burra P; Forns X; Diaz A; Londoño MC
    Gastroenterol Hepatol; 2020 Jan; 43(1):14-21. PubMed ID: 31495536
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients.
    Lee WC; Wu MJ; Cheng CH; Chen CH; Shu KH; Lian JD
    Am J Kidney Dis; 2001 Nov; 38(5):1074-81. PubMed ID: 11684562
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with hemato-oncological neoplasias treated with chemotherapy.
    Rossi G
    Leuk Lymphoma; 2003 May; 44(5):759-66. PubMed ID: 12802911
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fulminant hepatic failure due to chemotherapy-induced hepatitis B reactivation: role of rituximab.
    Stange MA; Tutarel O; Pischke S; Schneider A; Strassburg CP; Becker T; Barg-Hock H; Bastürk M; Wursthorn K; Cornberg M; Ott M; Greten TF; Manns MP; Wedemeyer H
    Z Gastroenterol; 2010 Feb; 48(2):258-63. PubMed ID: 20127601
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis B immunoglobulin in combination with lamivudine for prevention of hepatitis B virus reactivation in children undergoing bone marrow transplantation.
    Tavil B; Kuşkonmaz B; Kasem M; Demir H; Cetin M; Uçkan D
    Pediatr Transplant; 2006 Dec; 10(8):966-9. PubMed ID: 17096768
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis B virus reactivation in a patient undergoing steroid-free chemotherapy.
    Shimizu D; Nomura K; Matsumoto Y; Ueda K; Yamaguchi K; Minami M; Itoh Y; Horiike S; Morita M; Taniwaki M; Okanoue T
    World J Gastroenterol; 2004 Aug; 10(15):2301-2. PubMed ID: 15259089
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fulminant hepatic failure in a renal transplant recipient with positive hepatitis B surface antigens: a case report of fibrosing cholestatic hepatitis.
    Hung YB; Liang JT; Chu JS; Chen KM; Lee CS
    Hepatogastroenterology; 1995; 42(6):913-8. PubMed ID: 8847045
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease.
    Chen FW; Coyle L; Jones BE; Pattullo V
    Liver Int; 2013 Sep; 33(8):1203-10. PubMed ID: 23522150
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies.
    Kawatani T; Suou T; Tajima F; Ishiga K; Omura H; Endo A; Ohmura H; Ikuta Y; Idobe Y; Kawasaki H
    Eur J Haematol; 2001 Jul; 67(1):45-50. PubMed ID: 11553266
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.
    Huang H; Li X; Zhu J; Ye S; Zhang H; Wang W; Wu X; Peng J; Xu B; Lin Y; Cao Y; Li H; Lin S; Liu Q; Lin T
    JAMA; 2014 Dec; 312(23):2521-30. PubMed ID: 25514302
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy.
    Yeo W; Chan PK; Ho WM; Zee B; Lam KC; Lei KI; Chan AT; Mok TS; Lee JJ; Leung TW; Zhong S; Johnson PJ
    J Clin Oncol; 2004 Mar; 22(5):927-34. PubMed ID: 14990649
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.
    Giaccone L; Festuccia M; Marengo A; Resta I; Sorasio R; Pittaluga F; Fiore F; Boccadoro M; Rizzetto M; Bruno B; Marzano A
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):809-17. PubMed ID: 20060484
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adefovir dipivoxil therapy in liver transplant recipients for recurrence of hepatitis B virus infection despite lamivudine plus hepatitis B immunoglobulin prophylaxis.
    Akyildiz M; Karasu Z; Zeytunlu M; Aydin U; Ozacar T; Kilic M
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2130-4. PubMed ID: 18031370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.